TRAIL-functionalized nanoparticles in cancer therapy: Molecular mechanisms and translational opportunities

Dasari Sahithi1, Urushi Rehman1, Ramasubbamma Ramaiah2

  • 1Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.

Insights

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) nanoparticles enhance cancer treatment by improving drug delivery and overcoming resistance. This nanotechnology approach shows promise for personalized cancer therapy.

Area of Science:

  • Oncology
  • Nanomedicine
  • Molecular Biology

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces cancer cell death but faces clinical challenges like rapid clearance and tumor resistance.
  • Nanotechnology provides solutions to stabilize TRAIL, improve its pharmacokinetics, and enable targeted delivery to tumors.
  • TRAIL-based nanomedicines offer potential for overcoming drug resistance and enhancing apoptotic signaling in cancer treatment.

Purpose of the Study:

  • To review the mechanisms of TRAIL-mediated apoptosis and the design of TRAIL-functionalized nanoparticles.
  • To explore the integration of TRAIL nanomedicines with synergistic therapeutic strategies.
  • To discuss the translational potential and future directions for TRAIL nanomedicines in precision oncology.

Main Methods:

  • Review of preclinical studies on TRAIL-functionalized nanoparticles in various cancer models (e.g., triple-negative breast cancer, glioblastoma, colorectal carcinoma).
  • Analysis of lipid-based, polymeric, and metallic nanoparticle designs for TRAIL delivery.
  • Examination of combinatorial strategies involving TRAIL nanomedicines with chemotherapy, sensitizers, or immunomodulators.

Main Results:

  • TRAIL-functionalized nanoparticles demonstrate enhanced therapeutic efficacy and tumor-specific accumulation.
  • These nanocarriers improve TRAIL bioavailability and stability, overcoming pharmacokinetic limitations.
  • Combinatorial approaches using TRAIL nanoparticles show potential for overcoming intrinsic or acquired tumor resistance.
  • Preclinical studies report reduced systemic toxicity compared to conventional TRAIL administration.

Conclusions:

  • TRAIL-functionalized nanoparticles represent a promising strategy for precision oncology, combining molecular therapeutics with nanotechnology.
  • This approach holds significant translational potential for personalized cancer treatment by enhancing TRAIL efficacy and reducing toxicity.
  • Further research and development are needed to advance TRAIL nanomedicines toward clinical application.

Related Concept Videos

Mechanical Protein Functions01:58

Mechanical Protein Functions

Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force. 
5.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Mechanical Protein Function01:58

Mechanical Protein Function

2.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.0K